Most Active Stocks
Follow the most active stocks today, including share price changes, trading volume, and more. We cover the most traded stocks with daily market data, news, and analysis from our Foolish experts, helping you make informed investing decisions.
Related Articles
Featured Article
What Are the 3 Top Artificial Intelligence (AI) Stocks to Buy Right Now?
Geoffrey Seiler
|
Oct 1, 2025
Buying stocks in AI leaders could be a smart move.
Nvidia and OpenAI Just Upped the Ante in AI. Here's What Investors Should Watch.
Howard Smith
|
Oct 1, 2025
Tech companies are planning to spend hundreds of billions of dollars on AI infrastructure, and investors can take advantage of it.
After Getting a $5 Billion Investment From Nvidia, Is It Off to the Races for Intel's Stock?
David Jagielski
|
Oct 1, 2025
Shares of Intel have been rallying of late, but they're still down close to 30% over the past five years.
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
Adria Cimino
|
Oct 1, 2025
These stocks could see growth take off over the next few years.
The Best Growth Stocks to Buy With $100 Right Now
Jennifer Saibil
|
Oct 1, 2025
In a thriving bull market, growth stocks usually lead the pack.
The Best AI Stock to Buy Right Now, According to a Wall Street Analyst (Hint: Not Nvidia or Palantir)
Trevor Jennewine
|
Oct 1, 2025
Wedbush analyst Dan Ives think Tesla stock will soar 115% to a $3 trillion market value.
Prediction: This Will Be Nvidia's Stock Price in 2030
Adria Cimino
|
Oct 1, 2025
Is Nvidia on the road to more explosive growth?
3 Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 9.5% -- Which Are No-Brainer Buys in October
Sean Williams
|
Oct 1, 2025
Three supercharged income stocks have the catalysts necessary to pad the pocketbooks of patient investors.
Prediction: SoFi Will Be 1 of the Largest Banks in the U.S. in 10 Years
Jennifer Saibil
|
Sep 30, 2025
Get ready for the stock to reflect that.
Stock Market Today: Pfizer Rallies on Trump Drug Pricing Deal and U.S. Investment Pledge
Daily Stock News
|
Sep 30, 2025
Pfizer surged after striking a landmark agreement with the Trump administration to lower drug prices and expand U.S. production.
View More Articles